The radiation therapy of early stage cutaneous T-cell lymphoma

Bizhan Micaily; Charles Moser; Eric C. Vonderheid; Christopher Koprowski; David Lightfoot; Arnold Markoe; Luther Brady

doi:10.1016/0360-3016(90)90306-5

The radiation therapy of early stage cutaneous T-cell lymphoma

Bizhan Micaily, Charles Moser, Eric C. Vonderheid, Christopher Koprowski, David Lightfoot, Arnold Markoe, Luther Brady

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (

Original language	English (US)
Pages (from-to)	1333-1339
Number of pages	7
Journal	International Journal of Radiation Oncology, Biology, Physics
Volume	18
Issue number	6
DOIs	https://doi.org/10.1016/0360-3016(90)90306-5
State	Published - 1990
Externally published	Yes

Keywords

Complete response
Cutaneous T-cell lymphoma
Mechlorethamine hydrochloride
Total skin electron beam radiation

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Radiation

Access to Document

10.1016/0360-3016(90)90306-5

Cite this

@article{293a28ae68904de7b87758e0b759974c,

title = "The radiation therapy of early stage cutaneous T-cell lymphoma",

abstract = "Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (",

keywords = "Complete response, Cutaneous T-cell lymphoma, Mechlorethamine hydrochloride, Total skin electron beam radiation",

author = "Bizhan Micaily and Charles Moser and Vonderheid, {Eric C.} and Christopher Koprowski and David Lightfoot and Arnold Markoe and Luther Brady",

year = "1990",

doi = "10.1016/0360-3016(90)90306-5",

language = "English (US)",

volume = "18",

pages = "1333--1339",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - The radiation therapy of early stage cutaneous T-cell lymphoma

AU - Micaily, Bizhan

AU - Moser, Charles

AU - Vonderheid, Eric C.

AU - Koprowski, Christopher

AU - Lightfoot, David

AU - Markoe, Arnold

AU - Brady, Luther

PY - 1990

Y1 - 1990

N2 - Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (

AB - Results of different radiotherapy schedules used for early stage (T1-2, N0-1, M0) cutaneous T-cell lymphoma (CTCL) are compared in a series of 45 patients (22 patients treated with high dose total skin electron beam therapy (TSEB) with curative intent, 18 patients treated with palliative radiotherapy, and 5 patients treated with high dose local electron beam). At 3, 5, and 10 years after diagnosis the high dose TSEB treatment group had a probability of overall survival of 91%, 86%, and 75%, respectively, compared with 94%, 88%, and 88% for the palliative treatment group. The complete response (CR) rate for the high dose TSEB treatment group was 82% ( 18 22), compared with a 57% ( 4 7) complete response rate for seven patients in the palliative group who received low dose TSEB (

KW - Complete response

KW - Cutaneous T-cell lymphoma

KW - Mechlorethamine hydrochloride

KW - Total skin electron beam radiation

UR - http://www.scopus.com/inward/record.url?scp=0025363476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025363476&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(90)90306-5

DO - 10.1016/0360-3016(90)90306-5

M3 - Article

C2 - 1695214

AN - SCOPUS:0025363476

VL - 18

SP - 1333

EP - 1339

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 6

ER -

The radiation therapy of early stage cutaneous T-cell lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this